Analgesics alcohol warning to note possible liver, stomach problems under FDA proposal.
This article was originally published in The Tan Sheet
Executive Summary
FDA ALCOHOL WARNING SPECIFYING POTENTIAL ORGAN HARM PROPOSED for all OTC analgesics intended for adult use. Published in the Nov. 14 Federal Register, the proposed rule includes three warning statements: one for acetaminophen products that cautions against liver damage; one for aspirin, related ingredients and nonsteroidal anti-inflammatory drugs that cautions against stomach bleeding; and one for products containing combinations of acetaminophen and other analgesic/antipyretic ingredients that cautions against liver damage and stomach bleeding.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning